VinFuture Prize holds the distinction of being the first major international science and technology award to recognize and ...

Listen to Dr. Ilana Ressler explain PCOS and its significance in fertility and metabolic health on our latest episode.

The health services arm of The Cigna Group CI, Evernorth, recently introduced a pharmacy benefit offering designed to enhance ...

As demand for GLP-1 weight-loss medications like Wegovy and Zepbound continues to grow in the United States, so do questions about their affordability.

GLP-1 weight-loss drugs are reshaping dairy demand by curbing cravings for processed, fatty, and sugary products, fueling a ...

Final overall survival (OS) results from the INAVO120 trial (NCT04191499) confirmed that the addition of inavolisib (Itovebi) ...

The latest budget proposal to cut anti-obesity medication (AOM) coverage by Medi-Cal will cost the state more in the long run ...

The new weight-loss option will cut what the plan sponsors pay as well as what the patients pay, Cigna’s PBM Evernorth says.

The report takes from HHS Secretary Robert F. Kennedy’s playbook, calling out rising autism rates, the vaccine schedule and ...

The "Make America Healthy Again" report, commissioned by President Trump, highlights ultraprocessed foods and environmental toxins as driving causes of chronic disease.

Novo Nordisk has contracted California-based biotech Septerna to develop oral pills that target G protein-coupled receptors.

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud.